APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz
about
APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz
description
scientific article published on 08 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
APOBEC3G/3A Expression in Huma ...... ning Cenicriviroc or Efavirenz
@en
APOBEC3G/3A Expression in Huma ...... ning Cenicriviroc or Efavirenz
@nl
type
label
APOBEC3G/3A Expression in Huma ...... ning Cenicriviroc or Efavirenz
@en
APOBEC3G/3A Expression in Huma ...... ning Cenicriviroc or Efavirenz
@nl
prefLabel
APOBEC3G/3A Expression in Huma ...... ning Cenicriviroc or Efavirenz
@en
APOBEC3G/3A Expression in Huma ...... ning Cenicriviroc or Efavirenz
@nl
P2093
P2860
P356
P1476
APOBEC3G/3A Expression in Huma ...... ning Cenicriviroc or Efavirenz
@en
P2093
Clementina M Galluzzo
Cristina Purificato
Eric Lefebvre
Laura Catapano
Laura Fantuzzi
Maria Cristina Gauzzi
Mauro Andreotti
Star Seyedkazemi
Stefano Vella
P2860
P356
10.3389/FIMMU.2018.01839
P407
P577
2018-08-08T00:00:00Z